History of positron emission tomography (PET) in Poland
-
Paulina Cegła
and
Tomasz Piotrowski
Abstract
In this short chronological review, we showed the development of positron emission tomography (PET) starting from research on first isotopes through the concepts and prototype of PET machine to the current clinical practice and technological and clinical research. Particular emphasis was placed on a clear description of the milestones of PET development in Poland.
Research funding: None declared.
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
Competing interests: Authors state no conflict of interest.
Informed consent: Not applicable.
Ethical approval: Not applicable.
References
1. Teresińska, A, Birkenfeld, B, Królicki, L, Dziuk, M. Nuclear medicine training and practice in Poland. Eur J Nucl Med Mol Imag 2014;41:1995–9. https://doi.org/10.1007/s00259-014-2853-0.Search in Google Scholar
2. Gwardyrs, A, Cichon-Bańkowska, K. Najważniejsze wydarzenia w historii medycyny nuklearnej. In: Bierkenfeld, B, Listewnik, M, editors. Medycyna Nuklearna, Obrazowanie molekularne. Wydawnictwo Pomorskiego Uniwersytetu Medycznego w Szczecinie; 2011.Search in Google Scholar
3. Lawson, R. Przyczynki do historii medycyny nuklearnej, z podkreśleniem roli laureatów Nagród Nobla, NOWOTWORY. J Oncol 2012;62:385–90.Search in Google Scholar
4. Chesler, DA. Three-dimensional activity distribution from multiple positron scintigraphs. J Nucl Med 1971;12:347–34.Search in Google Scholar
5. Jones, T, Townsend, D. History and future technical innovation in positron emission tomography. J Med Imag (Bellingham) 2017;4:011013. https://doi.org/10.1117/1.jmi.4.1.011013.Search in Google Scholar
6. Alavi, A, Reivich, M, Greenberg, J, Hand, P, Rosenquist, A, Rintelmann, W, et al.. Mapping of functional activity in brain with 18F-fluoro-deoxyglucose. Semin Nucl Med 1981;11:24–31. https://doi.org/10.1016/s0001-2998(81)80050-5.Search in Google Scholar
7. Graban, W. Tomografia pozytronowa czyli kuszenie na pustyni. Przegląd Techniczny 1983;30:8–12.Search in Google Scholar
8. Królicki, L, Teresińska, A. Achievements of the Polish PET centers. Nucl Med Rev 2012;15(C Suppl):C1–4.10.5603/NMR.2012.0011Search in Google Scholar
9. Królicki, L., Kunikowska, J, Mączewska, J. Metoda pozytonowej tomografii emisyjnej w medycynie, 2012. Available from: https://instytucja.pan.pl/index.php/aktwydz5/1892-metoda-pozytonowej-tomografii-emisyjnej-w-medycynie [Accessed 23 Aug 2021].Search in Google Scholar
10. NIK. Radiofarmaceutyki. Niecertyfikowane 2019. Available from: https://www.nik.gov.pl/aktualnosci/niecertyfikowane-radiofarmaceutyki.html [Accessed 23 Aug 2021].Search in Google Scholar
11. Bedford, M, Maisey, MN. Requirements for clinical PET: comparisons within Europe. Eur J Nucl Med Mol Imag 2004;31:208–21. https://doi.org/10.1007/s00259-003-1351-6.Search in Google Scholar
12. Furtak, J, Rakowska, J, Szylberg, T, Harat, M, Małkowski, B, Harat, M. Glioma biopsy based on hybrid dual time-point FET-PET/MRI-a proof of concept study. Front Neurol 2021;11:634609. https://doi.org/10.3389/fneur.2021.634609.Search in Google Scholar
13. Maksim, R, Sierko, E, Hempel, D, Burzyńska-Śliwowska, J, Kidrycka, K, Szumowski, P, et al.. The usefulness of an 18F-FDG-PET/MR examination in a patient with rectal and breast cancer. A case report. Oncol Clin Pract 2019;15:180–4. https://doi.org/10.5603/ocp.2019.0015.Search in Google Scholar
14. Available from: https://laboratorium.elamed.pl/material.53068 [Accessed 12 Oct 2021].Search in Google Scholar
15. Kazakauskaitė, E, Žaliaduonytė-Pekšienė, D, Rumbinaitė, E, Keršulis, J, Kulakienė, I, Jurkevičius, R. Positron emission tomography in the diagnosis and management of coronary artery disease. Medicina (Kaunas) 2018;54:47.10.3390/medicina54030047Search in Google Scholar PubMed PubMed Central
16. Cegła, P, Ciepłucha, A, Pachowicz, M, Chrapko, B, Piotrowski, T, Lesiak, M. Nuclear cardiology: an overview of radioisotope techniques used in the diagnosis of cardiovascular disorders. Kardiol Pol 2020;78:520–8. https://doi.org/10.33963/KP.15396.Search in Google Scholar
17. Tripathi, M, Tripathi, M, Damle, N, Kushwaha, S, Jaimini, A, D’Souza, MM, et al.. Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT. NeuroRadiol J 2014;27:13–21. https://doi.org/10.15274/nrj-2014-10002.Search in Google Scholar
18. Zhuang, H, Codreanu, I. Growing applications of FDG PET-CT imaging in non-oncologic conditions. J Biomed Res 2015;29:189–202. https://doi.org/10.7555/JBR.29.20140081.Search in Google Scholar
19. Zhuang, H, Alavi, A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 2002;32:47–59. https://doi.org/10.1053/snuc.2002.29278.Search in Google Scholar
20. Alavi, A, Zhuang, H. Finding infection-help from PET. Lancet 2001;358:1386. https://doi.org/10.1016/s0140-6736(01)06491-1.Search in Google Scholar
21. Chrapko, BE, Chrapko, M, Nocuń, A, Zubilewicz, T, Stefaniak, B, Mitura, J, et al.. Patterns of vascular graft infection in 18F-FDG PET/CT. Nucl Med Rev 2020;23:63–70. https://doi.org/10.5603/nmr.a2020.0015.Search in Google Scholar
22. Lucignani, G, Orunesu, E, Cesari, M, Marzo, K, Pacei, M, Bechi, G, et al.. FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables. Eur J Nucl Med Mol Imag 2009;36:640–7. https://doi.org/10.1007/s00259-008-1023-7.Search in Google Scholar
23. Balink, H, Collins, J, Bruyn, GA, Gemmel, F. F-18 FDG PET/CT in the diagnosis of fever of unknown origin. Clin Nucl Med 2009;34:862–8. https://doi.org/10.1097/rlu.0b013e3181becfb1.Search in Google Scholar
24. Królicki, L, Bruchertseifer, F, Kunikowska, J, Koziara, H, Królicki, B, Jakuciński, M, et al.. Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma. Eur J Nucl Med Mol Imag 2019;46:614–22. https://doi.org/10.1007/s00259-018-4225-7.Search in Google Scholar
25. Kunikowska, J, Cieślak, B, Gierej, B, Patkowski, W, Kraj, L, Kotulski, M, et al.. [68Ga]Ga-prostate-specific membrane antigen PET/CT: a novel method for imaging patients with hepatocellular carcinoma. Eur J Nucl Med Mol Imag 2021;48:883–92. https://doi.org/10.1007/s00259-020-05017-0.Search in Google Scholar
26. Zakrzewska, A. The first digital PET/CT imaging system in Poland. 2020. Available from: https://www.united-imaging.eu/en/news/the-first-digital-pet-ct-imaging-system-in-poland [Accessed 22 Aug 2021].Search in Google Scholar
27. Moskal, P, Stępień, EŁ. Prospects and clinical perspectives of total-body PET imaging using plastic scintillators. PET Clin 2020;15:439–52. https://doi.org/10.1016/j.cpet.2020.06.009.Search in Google Scholar
28. Moskal, P, Kisielewska, DY, Shopa, R, Bura, Z, Chhokar, J, Curceanu, C, et al.. Performance assessment of the 2γ positronium imaging with the total-body PET scanners. EJNMMI Phys 2020;7:44. https://doi.org/10.1186/s40658-020-00307-w.Search in Google Scholar
29. Moskal, P, Gajos, A, Mohammed, M, Chhokar, J, Chug, N, Curceanu, C, et al.. Testing CPT symmetry in ortho-positronium decays with positronium annihilation tomography. Nat Commun 2021;12:5658. https://doi.org/10.1038/s41467-021-25905-9.Search in Google Scholar
30. Wawrowicz, K, Majkowska-Pilip, A, Gaweł, D, Chajduk, E, Pieńkowski, T, Bilewicz, A. Au@Pt core-shell nanoparticle bioconjugates for the therapy of HER2+ breast cancer and hepatocellular carcinoma. Model studies on the applicability of 193mPt and 195mPt radionuclides in auger electron therapy. Molecules 2021;26:2051. https://doi.org/10.3390/molecules26072051.Search in Google Scholar
31. Choiński, J, Kilian, K, Napiorkowski, PJ, Pęgier, M, Sentykowska, A, Stolarz, A, et al.. Radiopharmaceuticals production and research center at heavy ion laboratory of University of Warsaw. Acta Phys Pol, A 2021;139:413–6.10.12693/APhysPolA.139.413Search in Google Scholar
© 2021 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Editorial
- New trends in theranostics
- Reviews
- Unparalleled and revolutionary impact of PET imaging on research and day to day practice of medicine
- Research Articles
- Theranostics – present and future
- Peptide receptor radionuclide therapy as a tool for the treatment of severe hypoglycemia in patients with primary inoperable insulinoma
- History of radiotherapy in Poland. A brief outline of the problem
- Reviews
- Radioactive nuclei for β+γ PET and theranostics: selected candidates
- Prospects for the production of radioisotopes and radiobioconjugates for theranostics
- History of positron emission tomography (PET) in Poland
- Progress and perspectives in total body PET systems instrumentation
- Perspectives of brain imaging with PET systems
- Combined BNCT and PET for theranostics
- Novel biomarker and drug delivery systems for theranostics – extracellular vesicles
- Positronium as a biomarker of hypoxia
Articles in the same Issue
- Frontmatter
- Editorial
- New trends in theranostics
- Reviews
- Unparalleled and revolutionary impact of PET imaging on research and day to day practice of medicine
- Research Articles
- Theranostics – present and future
- Peptide receptor radionuclide therapy as a tool for the treatment of severe hypoglycemia in patients with primary inoperable insulinoma
- History of radiotherapy in Poland. A brief outline of the problem
- Reviews
- Radioactive nuclei for β+γ PET and theranostics: selected candidates
- Prospects for the production of radioisotopes and radiobioconjugates for theranostics
- History of positron emission tomography (PET) in Poland
- Progress and perspectives in total body PET systems instrumentation
- Perspectives of brain imaging with PET systems
- Combined BNCT and PET for theranostics
- Novel biomarker and drug delivery systems for theranostics – extracellular vesicles
- Positronium as a biomarker of hypoxia
